Complicated Urinary Tract Infection Treatment Market Trends 2025–2029: Forecasts for Key Growth Segments
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Does The Market Size Of The Complicated Urinary Tract Infection Treatment Industry Compare Between 2025 And 2029?
The complicated urinary tract infection treatment market size has experienced strong growth in recent years. It is forecast to expand from $8.87 billion in 2024 to $9.44 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.4%. The expansion observed in the past period can be attributed to a number of factors, including the increasing occurrence of urinary tract infections, a rise in antibiotic resistance, the growing elderly demographic, higher rates of hospitalization, and enhanced awareness regarding UTIs.
The complicated urinary tract infection treatment market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $12.03 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.2%. Factors contributing to this growth during the forecast period include the increasing occurrence of multidrug-resistant pathogens, a heightened emphasis on precision medicine, rising costs in healthcare, the expanded application of rapid diagnostic tests, as well as government programs and research funding. Key trends expected over the forecast period encompass improvements in diagnostic methods, broadened access to healthcare in developing regions, the creation of new antibiotics, further technological progress in diagnostic instruments, and the uptake of combination treatments.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21156&type=smp
Which Drivers Are Impacting The Complicated Urinary Tract Infection Treatment Market?
The increasing prevalence of chronic kidney diseases is anticipated to propel the expansion of the complicated urinary tract infection treatment market going forward. Chronic kidney disease (CKD) is defined as a long-term condition marked by the gradual deterioration of kidney function over time. The growing incidence of CKD largely results from rising rates of diabetes and hypertension, compounded by aging populations and lifestyle factors such as obesity and smoking. Complicated urinary tract infection treatment offers support to chronic kidney disease (CKD) patients by preventing severe infections like pyelonephritis, which can worsen kidney damage, compromise renal function, and accelerate the progression of chronic kidney disease, ultimately mitigating the risk of further complications and hospitalizations. For instance, in December 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that chronic kidney disease accounted for approximately 21,800 deaths in Australia in 2022. Moreover, Kidney Care UK, a UK-based non-profit organization, indicated in May 2024 that 40-45,000 premature deaths occur annually in the UK due to chronic kidney disease. Thus, the increasing occurrence of chronic kidney diseases is a significant driver for the complicated urinary tract infection treatment market.
What Are The Key Segments In The Complicated Urinary Tract Infection Treatment Market?
The complicated urinary tract infection treatmentmarket covered in this report is segmented –
1) By Drug Class: Penicillin And combinations; Quinolones; Cephalosporin; Azoles And Amphotericin B; Nitro furans
2) By Distribution Channel: Hospital Pharmacies; Gynecology And Urology Clinics; Drug stores
3) By Application: Urethritis; Cystitis; Pyelonephritis
Subsegments:
1) By Penicillin And Combinations: Aminopenicillins; Beta-Lactamase Inhibitor Combinations
2) By Quinolones: Fluoroquinolones; Non-Fluoroquinolones
3) By Cephalosporin: First-Generation Cephalosporins; Second-Generation Cephalosporins; Third-Generation Cephalosporins; Fourth-Generation Cephalosporins; Fifth-Generation Cephalosporins
4) By Azoles And Amphotericin B: Triazoles; Imidazoles; Polyene Antifungals
5) By Nitrofurans: Nitrofurantoin; Furazolidone
Which Key Trends Are Expected To Influence The Complicated Urinary Tract Infection Treatment Market In The Coming Years?
Leading companies within the complicated urinary tract infection treatment market are concentrating efforts on overcoming antibiotic resistance by developing new antibiotics to improve treatment effectiveness and address the emergence of multidrug-resistant pathogens. Such anti-infective therapies for complicated urinary tract infection treatment rely on targeted antibiotics or antimicrobial agents to eradicate or manage infections, particularly in severe instances involving kidney complications. As an example, in February 2024, Allecra Therapeutics, a biopharmaceutical firm based in Germany, declared that EXBLIFEP (cefepime/enmetazobactam) received U.S. Food and Drug Administration (FDA) approval for the treatment of complicated urinary tract infections (cUTIs) in adults. The company additionally obtained a five-year extension for marketing exclusivity, granted under the GAIN Act, which serves to stimulate the creation of novel anti-infective therapies. Research indicated that 79.1% of individuals receiving cefepime/enmetazobactam achieved a combined positive outcome (encompassing both clinical cure and microbiological eradication), in contrast to 58.9% of patients treated with piperacillin/tazobactam.
Who Are The Core Companies Influencing The Complicated Urinary Tract Infection Treatment Market Landscape?
Major companies operating in the complicated urinary tract infection treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., AstraZeneca PLC, Fresenius Kabi AG, GlaxoSmithKline plc, bioMérieux SA, Shionogi & Co. Ltd., Cipla Limited, Santen Pharmaceutical Co. Ltd., Orchid Pharma Limited, Melinta Therapeutics Inc., Spero Therapeutics Inc., Nabriva Therapeutics AG, Venatorx Pharmaceuticals Inc., Recce Pharmaceuticals Ltd, MerLion Pharmaceuticals Pte. Ltd., Entasis Therapeutics Holdings Inc., Allecra Therapeutics GmbH, Allergan Inc.
Download The Full Report For Exclusive Market Findings:
How Does The Complicated Urinary Tract Infection Treatment Market Perform Across Key Geographic Regions?
North America was the largest region in the complicated urinary tract infection treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complicated urinary tract infection treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Complicated Urinary Tract Infection Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=21156&type=smp
Browse Through More Reports Similar to the Global Complicated Urinary Tract Infection Treatment Market 2025, By The Business Research Company
Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Global Market Report 2025
Urinary Stone Treatment Devices And Equipment Global Market Report 2025
Genito Urinary Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
